Abstract-In adult mice we determined whether expression of angiotensin II (Ang II) type 1A receptors (AT 1A Rs) in C1 neurons mediates the excitation of the rostral ventrolateral medulla (RVLM) by Ang II. Blood pressure, heart rate, and sympathetic nerve activity were measured in anesthetized, artificially ventilated wild-type (nϭ15) and AT 1A R knockout (AT 1A Ϫ/Ϫ ; nϭ9) mice. Microinjection of Ang II (50 nL of 0.1 to 1.0 mmol/L) into the RVLM induced a dose-related, sympathetically mediated pressor response (maximum of 17Ϯ2 mm Hg) in wild-type mice. These microinjections had no effect in AT 1A Ϫ/Ϫ mice. Endogenous AT 1 Rs occur on catecholaminergic C1 neurons in the RVLM. We induced AT 1A R or green fluorescent protein expression in C1 neurons of AT 1A Ϫ/Ϫ mice through bilateral microinjection of replication-deficient lentiviruses, with transgene expression under the control of a phox2 transcription factor binding promoter (PRSx8) (Lv-PRSx8-AT 1A , nϭ10, and Lv-PRSx8-GFP, nϭ5). Transgene expression was observed in a significant proportion of RVLM C1 neurons. In anesthetized Lv-PRSx8-AT 1A injected mice, unilateral RVLM microinjection of Ang II (50 nL of 1 mmol/L) increased blood pressure (17Ϯ4 mm Hg) and sympathetic nerve activity (155Ϯ32%). No response to Ang II occurred in Lv-PRSx8-GFP microinjected mice. These results show that Ang II-mediated excitation of RVLM neurons in adult mice depends on the AT 1A R with little or no effect of type 1B or 2 receptors. Expression of the AT 1A R predominantly in C1 catecholamine neurons restores the response to Ang II in the AT 1A Ϫ/Ϫ mouse and demonstrates that these neurons are sympathoexcitatory in the mouse. (Hypertension. 2010;56:00-00.) Key Words: sympathetic Ⅲ blood pressure Ⅲ RVLM Ⅲ angiotensin II Ⅲ lentivirus Ⅲ catecholamine Ⅲ PRSx8 A ngiotensin II (Ang II) acts within the brain to modulate multiple functions, including autonomic control. These actions are exerted via 2 specific G protein-coupled receptors, Ang II type 1 (AT 1 R) and Ang II type 2 (AT 2 R) receptors. In rodents there are 2 homologous AT 1 Rs, termed AT 1A R and AT 1B R. 1,2 Most of the principal actions of Ang II in the rodent are exerted via the AT 1A R. 3 One brain site where Ang II regulates sympathetic vasomotor activity is the rostral ventrolateral medulla (RVLM). Neurons in the RVLM provide an essential excitatory drive for the generation and regulation of sympathetic vasomotor tone. 4 At least 2 major subtypes of RVLM neurons can be discriminated on the basis of expression of catecholamine synthetic enzymes, including tyrosine hydroxylase (TH). One group, the C1 neurons, expresses all of the enzymes required to synthesize adrenaline, 5 whereas the other group expresses none of these enzymes and is referred to as non-C1 neurons. 6, 7 In all of the mammals studied, including humans, the RVLM contains moderate to high levels of AT 1 R binding sites, 8 which, in adult rats, is attributable to expression of AT 1A R mRNA. 9 Microinjection of Ang II into the RVLM induces a sympathetically mediated increase in blood pressure (BP), 10 whereas microinjections of AT 1 R antagonists decrease sympathetic activity in several cardiovascular diseases. 11, 12 In slice preparations, C1 neurons are directly excited by Ang II, 13 but there is also evidence to indicate that other RVLM neurons might also be activated by Ang II. 14 In a superfused, neonatal mouse brain stem-spinal cord preparation, Ang II depolarizes RVLM neurons in wild-type mice but not in mice with targeted deletion of the AT 1A R (AT 1A Ϫ/Ϫ ). 15
A ngiotensin II (Ang II) acts within the brain to modulate multiple functions, including autonomic control. These actions are exerted via 2 specific G protein-coupled receptors, Ang II type 1 (AT 1 R) and Ang II type 2 (AT 2 R) receptors. In rodents there are 2 homologous AT 1 Rs, termed AT 1A R and AT 1B R. 1, 2 Most of the principal actions of Ang II in the rodent are exerted via the AT 1A R. 3 One brain site where Ang II regulates sympathetic vasomotor activity is the rostral ventrolateral medulla (RVLM). Neurons in the RVLM provide an essential excitatory drive for the generation and regulation of sympathetic vasomotor tone. 4 At least 2 major subtypes of RVLM neurons can be discriminated on the basis of expression of catecholamine synthetic enzymes, including tyrosine hydroxylase (TH). One group, the C1 neurons, expresses all of the enzymes required to synthesize adrenaline, 5 whereas the other group expresses none of these enzymes and is referred to as non-C1 neurons. 6, 7 In all of the mammals studied, including humans, the RVLM contains moderate to high levels of AT 1 R binding sites, 8 which, in adult rats, is attributable to expression of AT 1A R mRNA. 9 Microinjection of Ang II into the RVLM induces a sympathetically mediated increase in blood pressure (BP), 10 whereas microinjections of AT 1 R antagonists decrease sympathetic activity in several cardiovascular diseases. 11, 12 In slice preparations, C1 neurons are directly excited by Ang II, 13 but there is also evidence to indicate that other RVLM neurons might also be activated by Ang II. 14 In a superfused, neonatal mouse brain stem-spinal cord preparation, Ang II depolarizes RVLM neurons in wild-type mice but not in mice with targeted deletion of the AT 1A R (AT 1A Ϫ/Ϫ ). 15 The aim of this study was to test the hypothesis that, in the adult animal, the AT 1A R in the RVLM is responsible for the sympathetic activation in response to Ang II and that viral expression of the receptor in C1 neurons would restore this response. Furthermore, we predicted that expression of AT 1A R in C1 neurons would result in an increase in resting BP in the AT 1A R mouse.
Materials and Methods
Full details are included in the online Data Supplement, available at http://hyper.ahajournals.org.
Details of Mice
Experiments were performed on adult homozygous wild-type and AT 1A Ϫ/Ϫ mice. See the online Data Supplement for details.
Physiological Experiments
Mice were anesthetized by inhalation of isoflurane, followed by IP injection of urethane (0.75 mg/g) and chloralose (0.05 mg/g), and prepared for recording BP. 16 In some experiments, sympathetic nerve activity (SNA) was recorded from the right greater splanchnic nerve using a bipolar electrode. The SNA was amplified (20 000 gain), filtered (100 Hz to 2 kHz), and digitized (3 kHz sampling rate) using an A-D converter. Data were stored on a computer, analyzed, and displayed using Spike2 (Cambridge Electronic Design, U.K.). Stereotaxic microinjections were made with the skull level between bregma and lambda. Microinjections targeting the RVLM used the following coordinates: 1.2 mm lateral to the midline, 1.7 mm caudal to lambda, and 5.3 mm ventral to the dorsal surface of the brain. Microinjections were made through glass micropipettes, using pressurized nitrogen gas, and volumes determined by observation of movement of the fluid meniscus. Microinjections of L-glutamate (10 nL of 10 mmol/L solution) were used to functionally localize the RVLM after which Ang II was injected unilaterally at that site. In the AT 1A ϩ/ϩ mice, the response to unilateral RVLM microinjection of 50 nL of different concentrations of Ang II (100 mol/L, 200 mol/L, and 1 mmol/L solutions; Auspep) was determined. Doses were given randomly, with usually only 2 consecutive microinjections performed in each mouse. At least 30 minutes elapsed between microinjections. In the AT 1A Ϫ/Ϫ and lentiviral injected mice only the maximum concentration of Ang II (50 nL of 1 mmol/L of solution) was microinjected in the RVLM. The Ang II solution contained a 1% concentration of rhodaminelabeled microspheres (Molecular Probes) for histological verification of the microinjection site.
Lentiviral Microinjections
To induce expression of green fluorescent protein (GFP) or AT 1A Rs in C1 neurons of the RVLM of AT 1A Ϫ/Ϫ mice, lentiviral microinjections were made under anesthesia (ketamine [75 mg/kg] and xylazine [10 mg/kg] IP). Three 100-nL microinjections of lentivirus were made bilaterally (coordinates from lambda: anterior/posterior: 1.7, 1.9, and 2.1 mm; medial/lateral: 1.2 mm; dorsal/ventral: 5.3 mm). Mice were left for 11Ϯ1 weeks before either physiological experiments as described above or histological experiments to examine the distribution of transgene expression within the RVLM.
Generation of Lentiviruses
Lentiviruses were derived from the 4-plasmid HIV-1-based selfinactivating lentiviral vector system. 17 Either a rat AT 1A R carrying an N-terminal hemagglutinin epitope tag (YPYDVPDYA) from pRcCMV-NHAAT 1A plasmid 18 or GFP sequence was introduced into the cloning vector plasmid. Transgene expression was placed under control of the artificial phox2 transcription factor binding site promoter, PRSx8, to yield 2 viruses, Lv-PRSx8-AT 1A and LvPRSx8-GFP. Viruses were then produced as described in the Methods section of the online Data Supplement (http://hyper. ahajournals.org) and published previously. 19 
Immunohistochemistry
Mice that had been microinjected with Lv-PRSx8-GFP virus were deeply anesthetized and perfused through the heart with saline (0.9% NaCl), followed by a solution of 4% formaldehyde in 0.1 mol/L of sodium phosphate buffer. Immunohistochemistry was performed to localize TH and GFP.
Statistical Analysis
All of the data are expressed as meanϮSEM, and statistical significance is set at PϽ0.05. Mean arterial pressure (MAP) and heart rate (HR) were derived from the BP signal. Baseline cardiovascular and other parameters were measured in each animal and groups compared using a Student t test. For all of the microinjections of Ang II, 30-second periods of MAP and HR were averaged for 5 minutes of baseline (before Ang II microinjection) and 10 minutes after microinjection. The change in MAP after Ang II microinjection was compared with baseline by repeated-measure 1-way ANOVA. The responses of wild-type versus AT 1A Ϫ/Ϫ and Lv-PRSx8-AT 1A versus Lv-PRSx8-GFP mice were compared by repeated-measure 2-way ANOVA. Newman-Keuls multiple comparison test was applied.
The SNA was rectified and baseline noise subtracted and integrated with a 5-second time constant. Changes were expressed as a percentage of control baseline, and Student t test was used to compare the peak changes between the AT 1A Ϫ/Ϫ mice microinjected with either Lv-PRSx8-AT 1A or Lv-PRSx8-GFP. One-way ANOVA was used to compare the receptor binding densities in the RVLM across AT 1A ϩ/ϩ , AT 1A Ϫ/Ϫ , and AT 1A Ϫ/Ϫ injected with Lv-PRSx8-AT 1A mice followed by Newman-Keuls multiple comparisons test.
Results

General Parameters
For examination of the dose response to microinjection of Ang II into RVLM, the AT 1A ϩ/ϩ (nϭ15) and AT 1A Ϫ/Ϫ (nϭ9) mice were of similar age (18Ϯ2 versus 19Ϯ2 weeks) and weight (26Ϯ1 versus 26Ϯ1 g). Under anesthesia, the baseline BP was significantly higher in AT 1A ϩ/ϩ compared with AT 1A Ϫ/Ϫ mice (systolic BP: 85Ϯ3 versus 68Ϯ3 mm Hg; MAP: 71Ϯ3 versus 51Ϯ2 mm Hg; PϽ0.0001; Figure 1A) . HR was not different between AT 1A ϩ/ϩ and AT 1A Ϫ/Ϫ mice (453Ϯ31 versus 469Ϯ44 bpm).
RVLM Microinjections
For all of the experiments, initial identification of the RVLM was based on observation of a brisk pressor response to microinjection of a small volume (10 nL) and low concentration (10 mmol/L) of L-glutamate. The peak pressor response was similar in AT 1A ϩ/ϩ and AT 1A Ϫ/Ϫ mice (8.8Ϯ2 versus 8.1Ϯ2 mm Hg; Figure S1A Post hoc histological localization of fluorescent microspheres indicated that all of the Ang II microinjections were within the anatomic boundaries of the RVLM (defined in the Methods section of the online Data Supplement, Figure 1B ). Vehicle microinjections (saline, 50 nL) into the RVLM had no effect on BP or HR (data not shown).
Receptor Distribution
A low-to-moderate density of AT 1 Rs was observed within the anatomic boundaries of the RVLM in the AT 1A ϩ/ϩ mice ( Figure 1E , top). Higher density AT 1 R binding was also observed at this level in the nucleus of the solitary tract and nucleus of the spinal trigeminal tract. Binding to AT 1 and AT 2 Rs was observed in the inferior olivary nucleus (IO; Figure 1E ). In the AT 1A Ϫ/Ϫ mice there was a complete lack of AT 1 binding sites in most regions indicating that these are predominantly of the AT 1A R subtype in the AT 1A ϩ/ϩ mice ( Figure 1E, bottom) . Partial displacement of binding by losartan occurred in the IO of the AT 1A Ϫ/Ϫ mice, suggesting the presence of AT 1B Rs ( Figure 2B ).
Lentiviral-Induced Transgene Expression in the RVLM
Microinjections of lentiviruses were made into the RVLM of AT 1A Ϫ/Ϫ mice at 11Ϯ2 weeks of age. They were left to recover for 11Ϯ1 weeks, and at the end of this period these 22Ϯ1-week-old mice weighed 29Ϯ1 g. Under anesthesia, the baseline BP was not different between Lv-PRSx8-AT 1A (nϭ10) and Lv-PRSx8-GFP (nϭ5) microinjected AT 1A Ϫ/Ϫ mice (systolic BP: 55Ϯ3 versus 54Ϯ3 mm Hg, respectively; MAP: 41Ϯ2 versus 41Ϯ2 mm Hg, respectively; Figure 3A and 3B). There was a small difference in basal HR between the Lv-PRSx8-AT 1A and Lv-PRSx8-GFP microinjected mice (464Ϯ24 versus 533Ϯ14 bpm, respectively; PϽ0.05).
Microinjection of Lv-PRSx8-GFP resulted in strong expression of GFP in TH-immunoreactive neurons in the RVLM (Figure 2A ) and in processes of these neurons projecting to other regions of the medulla, including the contralateral RVLM and nucleus of the solitary tract, as described previously in the rat 22 (data not shown). Expression of GFP in non-TH-expressing neurons was also observed particularly in rostral RVLM at the level of the facial motor nucleus. These are presumed to be phox2b expressing neurons of the retrotrapezoid nucleus (Figure 2A , left column). 23 Post hoc analysis demonstrated that, at the level where Ang II was injected, indicated by the presence of rhodamine-labeled microspheres, 86Ϯ6% of GFP-labeled neurons expressed TH immunoreactivity. The section in the bottom panel of Figure  2A is representative of this level. At this level, 74Ϯ8% of TH neurons expressed GFP. Microinjection of the Lv-PRSx8-AT 1A resulted in increased expression of AT 1A Rs ( Figure 2B ) to 97Ϯ34% (nϭ10; PϽ0.5) above expression of the endogenous receptor in the RVLM ( Figure 2C ).
Response to Ang II in the RVLM of Lentiviral-Injected AT 1A
؊/؊ Mice Physiological experiments were performed Ϸ11 weeks after bilateral microinjection of either Lv-PRSx8-AT 1A or LvPRSx8-GFP into the RVLM of AT 1A Ϫ/Ϫ mice. Unilateral microinjection of 50 nL of 1 mmol/L of Ang II into the RVLM of Lv-PRSx8-AT 1A -injected mice induced a rapid and sustained increase in SNA, BP, and HR (Lv-PRSx8-GFP: ϩ14Ϯ6 bpm versus Lv-PRSx8-AT 1A : ϩ51Ϯ17 bpm; PϽ0.05; Figure 3A , 3C, and 3D). In contrast there was no response in any of the measured variables to unilateral RVLM microinjection of Ang II in the Lv-PRSx8-GFPinjected mice ( Figure 3B, 3C, and 3D) . The trend for a small decrease in BP in response to microinjection of Ang II in the RVLM of the Lv-PRSx8-GFP-injected mice was not statistically significant when compared with baseline ( Figure 3C ).
Discussion
We have demonstrated that the AT 1A R is the principal receptor subtype responsible for the pressor response to Ang II in the RVLM. Under basal conditions in adult anesthetized mice, we find no evidence for the involvement of other Ang II receptor subtypes in the RVLM response to exogenous Ang II. Receptor binding for Ang II is undetectable in the RVLM of the AT 1A Ϫ/Ϫ mouse, and there is no change in BP in response to microinjection of maximal doses of Ang II into this nucleus. After lentiviral-induced expression of AT 1A Rs in AT 1A Ϫ/Ϫ mice, Ang II microinjection into part of the RVLM where predominantly C1 neurons were transduced again induces a sympathetically mediated increase in BP. These observations demonstrate directly that C1 neurons are sympathoexcitatory neurons in the mouse, corroborating recent observations in the rat. 24 Microinjection of Ang II into the RVLM is sympathoexcitatory in all of the mammals studied, including the cat, 10 rat, 25 and rabbit. 26 This region contains a moderateto-high density of AT 1 Rs in all species, including humans. 27 Methodological difficulties have impeded understanding of the cellular distribution of Ang II type receptors in the RVLM. The RVLM contains 2 main classes of bulbospinal projection neurons, catecholaminergic C1 neurons and non-C1 neurons, of which their activity is considered essential for the generation and regulation of sympathetic vasomotor tone. 6, 7, 28, 29 In addition there are likely to be both inhibitory and excitatory interneurons within the RVLM that regulate activity of the premotor neurons. Autoradiographic observations in humans indicate that the receptor binding occurs over pigmented, presumably C1 neurons in the RVLM. 30 In slice preparations, in vitro RVLM premotor neurons are directly excited by Ang II. 13 However, Ang II superfusion in vitro also increases the rate of mini-excitatory postsynaptic potentials in RVLM neurons, suggesting that there might be an effect of Ang II on excitatory interneurons. 14 Although we demonstrate that expression of AT 1A Rs under the control of an artificial phox2 binding site promoter is sufficient to enable a pressor response to exogenous Ang II in the RVLM, this does not exclude the possibility that, in the wild-type animal, Ang II might affect other neuronal subtypes. In a superfused medulla-spinal cord preparation of the neonatal mouse (4 days of age) Ang II-induced excitation of RVLM neurons depends on the AT 1A R. 15 We confirm this in the intact adult mouse. Interestingly, in the superfused neonatal preparation, Ang II hyperpolarized RVLM neurons in AT 1A
Ϫ/Ϫ mice via activation of the Ang II type 2 receptor. In the intact adult AT 1A Ϫ/Ϫ mouse, we observe no change in BP after microinjection of Ang II into RVLM and cannot detect AT 2 R binding in the RVLM. Higher density and more widespread expression of the AT 2 receptor are observed in the brain during development, 31 but in the adult this is contracted to only a few sites and, under basal conditions, not detectable in the RVLM. [31] [32] [33] [34] Decreased AT 2 R expression in the RVLM has been reported in heart failure using PCR methods. 35 It may, therefore, be possible that there is a role for Ang II acting via the AT 2 R. The conclusion from our studies is that AT 2 R expression is below the detection limit of our autoradiographic method in the RVLM of the adult mouse and that it is not expressed at a level that induces inhibition of RVLM neurons in response to Ang II.
This study uses urethane/chloralose anesthetized mice as the experimental model, and this significantly reduces the resting BP of these mice. When recorded in the same laboratory, the AT 1A Ϫ / Ϫ mice had an MAP of 72Ϯ5 mm Hg when conscious and 42Ϯ3 mm Hg under anesthesia. 36 The BP recorded under anesthesia in this study is very similar to that already published by us for the same mouse lines. 37 Although we are concerned at the lower BP, we maintained strict criteria so that mice received sufficient anesthetic to induce and maintain a surgical anesthetic plane with total loss of the pedal withdrawal and corneal reflexes. Stable recordings of BP and SNA were maintained throughout the 5 to 6 hours required for the experiments, indicating that BP remained sufficiently high to ensure adequate tissue perfusion. Pulse modulation of the SNA was also observed in both AT 1A
ϩ/ϩ and AT 1A Ϫ/Ϫ mice, indicating that the BP was within the operating range of the baroreceptor reflex. In preliminary experiments, blood gases were measured to ensure that P CO2 remained in the range of 4.0% to 4.5%. Basal BP under anesthesia was reduced further in lentiviral-injected mice independent of the transgene being expressed. We conclude that this effect on BP is not because of AT 1A R expression in the RVLM of the AT 1A Ϫ/Ϫ mice but probably because of an effect of the second exposure to general anesthesia, coupled with increased age at experimentation.
Several studies have demonstrated that mice lacking the AT 1A R have reduced BP. The mechanisms responsible for this are complex and probably include developmental changes, as well as loss of Ang II effect in multiple tissues.
Crowley et al 38 elegantly demonstrated that a component of the decreased BP in the AT 1A Ϫ/Ϫ mice could be restored by transplantation of wild-type kidneys. We had hypothesized that expression of AT 1A R in C1 neurons of RVLM in the AT 1A Ϫ/Ϫ mouse might also lead to an increase in basal BP. However, we conclude from our observations that there is no change in basal BP, although this will need to be confirmed in conscious mice. A lack of effect is perhaps not surprising given that microinjection of AT 1 R antagonists into the RVLM of anesthetized control animals does not have a significant effect on SNA or BP. 39 In addition, transgenic mice with neuronal overexpression of the AT 1A R exhibit exaggerated pressor responses to intracerebroventricular administration of Ang II but have a normal resting BP. 40 These data indicate that there is little or no tonic stimulation of the AT 1A R in the brain of a normotensive animal and that an increased density of AT 1A Rs alone is not sufficient to produce sustained increases in BP. This conclusion accords with our observation that expression of a constitutively active AT 1A R mutant (N111G), but not the wild-type AT 1A R, in astrocytes increased BP in the rat. 21 Thus, activation of the receptor, and not just increased expression, is required for an altered phenotype.
As has been demonstrated in the rat, we show that lentiviral-induced transgene expression under control of the PRSx8 promoter occurs in a large proportion of catecholaminergic neurons of the RVLM. 28 Significant expression of the transgenes also occurs in noncatecholaminergic neurons localized in the rostral part of the RVLM and close to the ventral surface of the brain stem underlying the facial nucleus. 24 Neurons in this region express phox2b and not catecholamine-synthesizing enzymes and are considered part of the retrotrapezoid nucleus. Based on previous data, which demonstrated that activation of the retrotrapezoid neurons did not affect SNA or BP, 23, 24 we are confident that the effects observed in this study are attributed to activation of C1 neurons and not retrotrapezoid neurons. The specificity of our injection protocols also increases the veracity of this observation. Although our lentiviral injections were extensive over the rostro-caudal extent of the RVLM, our Ang II injections were smaller and targeted to the physiologically defined pressor region of the RVLM, within 400 m of the facial motor nucleus. At this level, 86% of the virally transduced neurons were TH expressing. Given that there is considerable variation in the relative level of TH expression among neurons, this figure is probably an underestimate. In addition, 74% of TH neurons expressed GFP, suggesting that the Ang II-evoked response probably did not involve excitation of all of the C1 neurons in RVLM. Together the data strongly support the view that the sympathetic activation observed after Ang II microinjection in the LvPRSx8-AT 1A -injected mice was likely because of direct stimulation of the C1 neurons. However, we cannot rule out a contribution to the observed pressor response from the other cell types that were transduced by this virus.
When expressed by the lentivirus, the AT 1A R is apparently correctly packaged and transported to the cell membrane, where it presents as a binding site with normal ligand interaction. In addition, the virally expressed receptor links appropriately with its intracellular G protein to induce an excitatory cascade, as is observed for the wild-type, endogenously expressed AT 1A R. When activated in C1 neurons, this induces a robust and rapid sympathetically mediated increase in BP and HR. The time course of the response is consistent with that expected from a G protein-coupled receptormediated neuronal activation.
Our results are also consistent with those published recently in the rat using the same viral construct to induced expression of the bacterial channel rhodopsin. 23 These studies demonstrate directly that activation of C1 neurons can elicit a large increase in SNA. Before these observations, the function of the C1 neurons in regulating SNA was not clear. Although they compose a major proportion of the bulbospinal neurons within the RVLM and are glutamatergic neurons, a functional role had not been definitively demonstrated. Indeed, lesions of the C1 neurons showed surprisingly small changes in SNA with decreases in BP of 10 to 15 mm Hg. 22, 41, 42 It is now clear that C1 neurons have the potential to induce large changes in SNA with consequent increases in both BP and HR. The critical question is what role do these neurons play in producing basal SNA and in the changes in SNA produced by physiological and pathological perturbations.
Perspectives
Using a lentivirus to direct expression of a G protein-coupled receptor to a specific neuronal cell type, we have shown long-lasting, stable expression of a functional receptor that couples to second messenger signaling pathways and induces a physiological response to administration of ligand. As a result of this approach, we show that in the mouse, C1 neurons of the RVLM have the capacity to induce a sympathetically mediated increase in BP and, thus, are likely to play a role in the regulation of BP. This is at odds with lesion studies that indicate that these neurons do not play a critical role in the maintenance of BP. Further studies need to elucidate the role of these cells in physiological regulation of BP and determine whether their function is altered in cardiovascular disease. We also show that expression of AT 1A Rs in the RVLM is required for the sympathoexcitation induced by Ang II in this nucleus. We found no evidence to support a role for the AT 2 R in the RVLM of the adult male mouse. Furthermore, re-expression of the AT 1A R predominantly in C1 neurons restores an Ang II-mediated pressor response. Given that inhibition of AT 1 Rs in the RVLM reduces BP in several hypertensive rat models, the findings suggest that altered function of C1 neurons might be an important component in hypertension. 
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